Core Scientific, Inc.
CORZ
$22.79
-$0.16-0.70%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -13.45% | 79.62% | 28.07% | -44.90% | -2,928.45% |
| Total Depreciation and Amortization | -31.19% | -33.25% | -24.35% | -11.87% | 6.46% |
| Total Amortization of Deferred Charges | 22.97% | 59.58% | 94.93% | 219.45% | 241.93% |
| Total Other Non-Cash Items | 22.72% | -103.17% | -57.35% | 14.52% | 2,120.35% |
| Change in Net Operating Assets | 6,755.08% | 1,997.94% | 311.03% | 276.61% | -79.74% |
| Cash from Operations | 2,438.61% | 538.31% | 164.88% | -83.22% | -136.11% |
| Capital Expenditure | -600.32% | -663.01% | -514.67% | -436.65% | -216.12% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -97.07% | -6,484.85% | -8,160.87% | -2,007.38% | -796.55% |
| Cash from Investing | -579.16% | -673.50% | -668.00% | -653.36% | -359.98% |
| Total Debt Issued | -5.93% | -- | 36.31% | -- | -- |
| Total Debt Repaid | 88.45% | 87.84% | 83.90% | -373.19% | -389.56% |
| Issuance of Common Stock | 30.58% | -88.46% | -91.71% | -90.70% | -90.64% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 77.06% | -- | -109.35% | -123.15% | -123.15% |
| Cash from Financing | 19.90% | -107.70% | 174.19% | 13,454.72% | 6,989.02% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -23.47% | -168.50% | 5.15% | 2,280.14% | 1,199.24% |